Sign In
Buy HTBX
$2.38
+0 (+0%)
At Close: Aug 17, 2022
Sesen Bio Reports Second Quarter 2020 Financial Results and Business Update
12:00am, Monday, 10'th Aug 2020
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, tod
Innovent Biologics : and Lilly Release Clinical Trial Results of Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous NSCLC in an Oral Presentation at IASLC WCLC 2020 Virtual Presidential Symposium | MarketScreener
01:01pm, Saturday, 08'th Aug 2020
Opdivo Plus Yervoy Demonstrates Durable Survival Benefit vs. Chemotherapy in Patients with Previously Untreated Malignant Pleural Mesothelioma
Heat Biologics Provides Second Quarter 2020 Business Update
11:00am, Friday, 07'th Aug 2020
* Progress on COVID-19 Vaccine Program * Reports over $100 million in cash and short-term investments as of August 6, 2020DURHAM, NC / ACCESSWIRE / August 7, 2020 / Heat Biologics, Inc.
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces CStone Pharmaceuticals (“CStone”, HKEX: 2616) recently reported that its OmniAb-derived a
DS Announces Clinical Trial Collaboration with AZ to Evaluate Patritumab Deruxtecan (U3-1402) in Combination with TAGRISSO in EGFR-Mutated NSCLC
Heat Biologics Highlights Importance of T cell Immunity to Prevent COVID-19
11:30am, Wednesday, 05'th Aug 2020
White paper highlights potential of Heat's vaccine to boost T cell immunity, alone or in combination with other vaccines DURHAM, NC / ACCESSWIRE / August 5, 2020 / Heat Biologics, Inc.
Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
12:00am, Tuesday, 04'th Aug 2020
Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
2 Risky Coronavirus Vaccine Stocks That Could Make You Filthy Rich
02:00pm, Monday, 03'rd Aug 2020
Companies at the forefront of coronavirus vaccine research have been a veritable gold mine for investors this year. For example, shares of Moderna (NASDAQ: MRNA) have gained a staggering 278% over th
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) („Takeda“) gab heute die Finanzergebnisse für das erste Quartal des Geschäftsjahres 2020 (
Heat Biologics, Inc. (NASDAQ:HTBX) Analysts Just Slashed This Year's Revenue Estimates By 12%
01:07pm, Thursday, 30'th Jul 2020
The latest analyst coverage could presage a bad day for Heat Biologics, Inc. (NASDAQ:HTBX), with the analysts making...
Why Heat Biologics Stock Is Spiking Today
04:05pm, Wednesday, 29'th Jul 2020
Heat Biologics (NASDAQ: HTBX), a prerevenue biotech, is off to a strong start today. Specifically, Heat announced that its COVID-19 vaccine candidate exhibited compelling evidence of immunogenicity (
Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies
11:30am, Wednesday, 29'th Jul 2020
Confirms stimulation of human-HLA-restricted transgenic mouse T-cells against immunodominant epitopes of SARS-CoV-2 Spike proteinDURHAM, NC / ACCESSWIRE / July 29, 2020 / Heat Biologics, Inc.
